Centene Q1 adjusted EPS rises 28% to $2.90; 2025 revenue guidance raised $6.0 billion
Centene reported first quarter 2025 results on April 25, 2025, with adjusted diluted EPS of $2.90, up 28% from $2.26 a year earlier, and GAAP diluted EPS of $2.63 versus $2.16. Premium and service revenues rose 17% to $42.5 billion, and the company raised its 2025 premium and service revenue guidance by $6.0 billion to a range of $164.0 billion to $166.0 billion while reiterating full-year adjusted diluted EPS guidance of greater than $7.25. For shareholders, the filing shows higher profit and a higher revenue outlook, though the health benefits ratio rose to 87.5% from 87.1%.
Key points
- Adjusted diluted EPS was $2.90 versus $2.26 in Q1 2024; GAAP diluted EPS was $2.63 versus $2.16.
- Premium and service revenues increased 17% to $42.5 billion from $36.3 billion.
- 2025 premium and service revenue guidance raised by $6.0 billion, citing $5.0 billion of additional Marketplace premium revenue and $1.0 billion from the Medicare Advantage annual enrollment period.
- Full-year 2025 adjusted diluted EPS guidance of greater than $7.25 was reiterated; GAAP diluted EPS guidance of greater than $6.19 was also reiterated.
The filing
Written by AI on Nov 8, 2026, 1:30 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 24, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.